EUVIMEDEUVIMED entdecken
Open Access

Changes in Clinical Outcomes and Peripheral Cytokines during Duloxetine Add‐on Therapy in Parkinson's Disease

Juliana Oliveira Freitas Silveira iD, Jamir Pitton Rissardo iD, Ana Letícia Fornari Caprara iD, Amanda Fernandes Klajn iD, Fernanda Rossatto Temp iD, Bruna Amanda Girardi iD, Marta Maria Medeiros Frescura Duarte, Thiago Duarte, Paulo Gilberto Medeiros Jauris iD, Carlos Fernando Mello iD

Movement Disorders Clinical Practice · 05.11.2026

DOI: 10.1002/mdc3.70885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 05.11.2026. Verfasst von Juliana Oliveira Freitas Silveira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital Universitário de Santa Maria, HUSM, Santa Maria, Brazil. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuroinflammation is implicated in Parkinson's disease (PD), and antidepressants may have anti‐inflammatory and motor benefits. The effects of duloxetine on inflammatory biomarkers and clinical outcomes in PD remain unclear.

Objectives

To assess changes in motor symptoms, quality of life, and serum cytokines during add‐on duloxetine treatment in PD.

Methods

Seventeen patients with PD without other chronic inflammatory diseases received add‐on duloxetine for 8 weeks in an open‐label, uncontrolled trial. Clinical outcomes included Unified Parkinson's Disease Rating Scale (UPDRS), modified Hoehn and Yahr (HY), and Parkinson's Disease Questionnaire‐39 (PDQ‐39) scores. Serum TNF‐α, IL‐1β, IL‐6, and IL‐10 levels were measured at baseline and follow‐up.

Results

UPDRS, activities of daily living, and PDQ‐39 scores decreased during treatment. Ten patients achieved ≥5‐point UPDRS reductions. TNF‐α, IL‐1β, and IL‐6 decreased, whereas IL‐10 increased after treatment.

Conclusions

Add‐on duloxetine was associated with changes in clinical outcomes and inflammatory markers in patients with PD.

Schlagwörter

Stichwörter der Autor:innen

SNRISSRIUPDRSneuroinflammationparkinsonism

Autor:innen und Institutionen

  • Department of Neurology, Hospital Universitário de Santa Maria, HUSM, Santa Maria, Brazil.
  • Pharmacology Graduate Program, Universidade Federal de Santa Maria UFSM, Santa Maria, Brazil.
  • Neurology Department, Cooper University Hospital, Camden, New Jersey, USA.
  • Biochemical Toxicology Graduate Program, Universidade Federal de Santa Maria, UFSM, Santa Maria, Brazil.

ORCID-Profile: Juliana Oliveira Freitas Silveira, Jamir Pitton Rissardo, Ana Letícia Fornari Caprara, Amanda Fernandes Klajn, Fernanda Rossatto Temp, Bruna Amanda Girardi, Paulo Gilberto Medeiros Jauris, Carlos Fernando Mello

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Silveira, J. O. F., Rissardo, J. P., Caprara, A. L. F., Klajn, A. F., Temp, F. R., Girardi, B. A., Duarte, M. M. M. F., Duarte, T., Jauris, P. G. M., & Mello, C. F. (2026). Changes in Clinical Outcomes and Peripheral Cytokines during Duloxetine Add‐on Therapy in Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70885

Vancouver

Silveira JOF, Rissardo JP, Caprara ALF, Klajn AF, Temp FR, Girardi BA, et al. Changes in Clinical Outcomes and Peripheral Cytokines during Duloxetine Add‐on Therapy in Parkinson's Disease. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70885

BibTeX
@article{Silveira2026,
  author = {Silveira, Juliana Oliveira Freitas and Rissardo, Jamir Pitton and Caprara, Ana Letícia Fornari and Klajn, Amanda Fernandes and Temp, Fernanda Rossatto and Girardi, Bruna Amanda and Duarte, Marta Maria Medeiros Frescura and Duarte, Thiago and Jauris, Paulo Gilberto Medeiros and Mello, Carlos Fernando},
  title = {Changes in Clinical Outcomes and Peripheral Cytokines during Duloxetine Add‐on Therapy in Parkinson's Disease},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  doi = {10.1002/mdc3.70885}
}
Kostenlos starten →